Seroba’s investee company, PQ Bypass, today announced data from a subset analysis of the DETOUR I clinical trial during a late-br... Read more

Professor Thomas Zeller MD announced new significant outcomes from the Mimics Study today at the 15th Annual Conference on Vascular Int... Read more

Managing Partner of Seroba Life Sciences has been appointed Chairman of the Irish Venture Capital Association (IVCA). To mark the appoi... Read more

LONDON, U.K.   August 31, 2017. Frost & Sullivan has announced PQ Bypass as winner of the 2017 European PAD Interventions Technol... Read more

TOP